See more : Sparinvest INDEX Mellem Risiko KL (SPVIMRKL.CO) Income Statement Analysis – Financial Results
Complete financial analysis of Lineage, Inc. (LINE) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Lineage, Inc., a leading company in the REIT – Industrial industry within the Real Estate sector.
You may be interested
- Sharing Services Global Corporation (SHRG) Income Statement Analysis – Financial Results
- Zhixin Group Holding Limited (ZHIXF) Income Statement Analysis – Financial Results
- Namsun Aluminum Co., Ltd. (008355.KS) Income Statement Analysis – Financial Results
- Solitaire Machine Tools Limited (SOLIMAC.BO) Income Statement Analysis – Financial Results
- Daishin Securities Co., Ltd. (003540.KS) Income Statement Analysis – Financial Results
Lineage, Inc. (LINE)
About Lineage, Inc.
Lineage, Inc. engages in the provision of temperature-controlled warehouse real estate investment trust (REIT). It operates through the Global Warehousing and Global Integrated Solutions segments. The Global Warehousing segment composes of industrial real estate properties to provide temperature-controlled warehousing services to its customers. The Global Integrated Solutions segment consists of specialized cold-chain services. The company was founded in 2008 and is headquartered in Novi, MI.
| Metric | 2023 | 2022 | 2021 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5.34B | 4.93B | 3.70B | 517.82M | 826.68M | 917.71M | 2.88B | 4.98B | 2.33B | 1.77B | 1.62B | 772.28M | 4.38M | 12.85M | 15.54M |
| Cost of Revenue | 3.59B | 3.47B | 2.57B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 1.75B | 1.46B | 1.13B | 517.82M | 826.68M | 917.71M | 2.88B | 4.98B | 2.33B | 1.77B | 1.62B | 772.28M | 4.38M | 12.85M | 15.54M |
| Gross Profit Ratio | 32.73% | 29.53% | 30.54% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| Research & Development | 0.00 | -0.01 | -0.06 | 43.30M | 3.14M | 4.08M | 9.47M | 125.04M | 5.25M | 1.92M | 2.39M | 5.17M | 7.17M | 7.60M | 0.00 |
| General & Administrative | 593.10M | 398.90M | 289.30M | 60.87M | 34.61M | 201.34M | 222.76M | 157.81M | 182.10M | 135.81M | 127.40M | 95.11M | 81.75M | 64.55M | 41.65M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 82.94M | 36.51M | 74.13M | 135.26M | 54.17M | 37.39M | 5.87M | 3.97M | 4.38M | 12.85M | 15.54M |
| SG&A | 593.10M | 398.90M | 289.30M | 60.87M | 117.55M | 237.84M | 296.89M | 293.07M | 236.27M | 173.21M | 133.27M | 99.08M | 86.13M | 77.39M | 57.19M |
| Other Expenses | 1.44B | 2.30M | 4.50M | 0.00 | 208.45M | 317.05M | 617.76M | 805.16M | 410.42M | 349.52M | 264.66M | 177.98M | 39.34M | 30.41M | 31.34M |
| Operating Expenses | 2.03B | 1.08B | 893.00M | 104.18M | 329.13M | 558.97M | 924.12M | 1.22B | 651.94M | 524.64M | 400.32M | 282.22M | 132.65M | 115.40M | 88.53M |
| Cost & Expenses | 5.62B | 4.55B | 3.46B | 293.28M | 69.46M | 1.41B | 7.81B | 4.83B | 2.59B | 1.76B | 816.42M | 613.74M | 132.65M | 115.40M | 88.53M |
| Interest Income | 0.00 | 3.20M | 3.70M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 222.10M | 367.20M | 235.00M | 8.35M | 12.36M | 192.86M | 546.45M | 587.84M | 421.14M | 379.94M | 259.73M | 193.51M | 92.70M | 94.52M | 62.13M |
| Depreciation & Amortization | 759.70M | 4.58B | 3.62B | 161.72M | 137.42M | 417.59M | 840.50M | 1.12B | 850.82M | 631.75M | 357.91M | 265.55M | 21.82M | 17.02M | 97.96M |
| EBITDA | 452.00M | 1.06B | 841.00M | 386.30M | 971.59M | -1.55B | -3.38B | 1.27B | 578.42M | 627.86M | 1.06B | 349.01M | -179.45M | 1.11B | -207.83M |
| EBITDA Ratio | 8.46% | 21.11% | 22.39% | 74.60% | 117.53% | -168.92% | -117.20% | 25.39% | 24.81% | 35.39% | 65.43% | 45.19% | -4,096.94% | 8,628.72% | -1,337.63% |
| Operating Income | -281.20M | 297.30M | 87.70M | 224.54M | 741.61M | -374.50M | -4.77B | -447.37M | -691.34M | -386.62M | 438.44M | -110.05M | -295.84M | 825.66M | -360.78M |
| Operating Income Ratio | -5.26% | 6.03% | 2.37% | 43.36% | 89.71% | -40.81% | -165.30% | -8.98% | -29.65% | -21.79% | 27.02% | -14.25% | -6,754.36% | 6,427.35% | -2,322.04% |
| Total Other Income/Expenses | -248.60M | -367.30M | -293.50M | -8.35M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -4.22M | 2.71M | 0.00 |
| Income Before Tax | -529.80M | -70.00M | -205.80M | 216.19M | 741.61M | -374.50M | -4.77B | -447.37M | -691.34M | -386.62M | 438.44M | -110.05M | -300.06M | 828.37M | -360.78M |
| Income Before Tax Ratio | -9.92% | -1.42% | -5.56% | 41.75% | 89.71% | -40.81% | -165.30% | -8.98% | -29.65% | -21.79% | 27.02% | -14.25% | -6,850.73% | 6,448.46% | -2,322.04% |
| Income Tax Expense | -45.40M | 6.00M | -29.30M | 356.90M | 388.94M | 11.19M | -6.46M | 4.44M | -2.20M | 2.79M | 5.47M | 4.24M | 4.22M | -2.71M | -3.57M |
| Net Income | -437.10M | -62.70M | -153.30M | -140.67M | 432.86M | -2.17B | -4.76B | -451.81M | -691.34M | -386.62M | 438.44M | -114.29M | -298.19M | 999.62M | -364.35M |
| Net Income Ratio | -8.18% | -1.27% | -4.14% | -27.17% | 52.36% | -236.66% | -165.08% | -9.07% | -29.65% | -21.79% | 27.02% | -14.80% | -6,808.04% | 7,781.54% | -2,345.04% |
| EPS | -2.08 | -0.30 | -0.73 | -0.92 | 4.94 | -6.16 | -13.86 | -1.37 | -2.91 | -1.90 | 2.55 | -0.80 | -2.50 | 8.76 | -0.01 |
| EPS Diluted | -2.08 | -0.30 | -0.73 | -0.92 | 4.88 | -6.16 | -13.86 | -1.37 | -2.91 | -1.90 | 2.54 | -0.80 | -2.50 | 8.75 | -0.01 |
| Weighted Avg Shares Out | 210.20M | 210.80M | 210.80M | 152.23M | 87.65M | 352.65M | 343.32M | 328.92M | 237.54M | 203.78M | 172.00M | 142.54M | 119.31M | 114.14M | 68.92B |
| Weighted Avg Shares Out (Dil) | 210.20M | 210.80M | 210.80M | 152.23M | 88.72M | 352.65M | 343.32M | 328.92M | 237.54M | 203.78M | 172.73M | 142.54M | 119.31M | 114.26M | 68.92B |
Double-Digit Return Potential: 3 REITs To Boost Your Portfolio
The bond market is acting strangely. Yields are rising despite rate cuts, and credit spreads are tightening. This unusual behavior is causing uncertainty and volatility. REITs, especially those sensitive to long-term interest rates, are becoming more attractive due to rising...
PREFORMED LINE PRODUCTS ANNOUNCES THIRD QUARTER 2024 FINANCIAL RESULTS
CLEVELAND , Oct. 30, 2024 /PRNewswire/ -- Preformed Line Products Company (NASDAQ: PLPC) today reported financial results for its third quarter of 2024. Net sales in the third quarter of 2024 were $147.0 million compared to $160.4 million in the third...
NORWEGIAN CRUISE LINE® UNVEILS MORE TO DO ABOARD NORWEGIAN AQUA™ AND NORWEGIAN LUNA™ WITH IMMERSIVE GAMING VENUES AND ELEVATED SPA AND FITNESS OFFERINGS
-The Company Will Debut a Brand-New Experience - Aqua and Luna Game Zone – Along with Returning Expanded Attractions - - Both Ships to Feature Enhanced Spa Services Including a New Clay Sauna and IV Drip Therapy - MIAMI ,...
VALUE LINE, INC. DECLARES A QUARTERLY CASH DIVIDEND OF $0.30 PER COMMON SHARE
New York, Oct. 18, 2024 (GLOBE NEWSWIRE) -- Value Line, Inc. (NASDAQ: VALU ) announced today that its Board of Directors declared on October 18, 2024 a quarterly cash dividend of $0.30 per common share, payable on November 12, 2024,...
Global IPO Activity Picking Up But Continues To Lag Other Post-COVID Years
Global IPO activity is recovering but remains below recent years, with 326 IPOs in Q3 2024 totaling $23.32 billion, the lowest since Q1 2019. US IPO activity has increased steadily, with 36 IPOs in Q3 2024, and $26.28 billion raised...
Lineage Cell Therapeutics to Present at the Maxim Group 2024 Virtual Healthcare Summit
CARLSBAD, Calif.--(BUSINESS WIRE)---- $LCTX #LineageCellTherapeutics--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced that Brian M. Culley, Lineage's Chief Executive Officer, will be presenting at the...
Top 3 Real Estate Stocks That May Explode This Quarter
The most oversold stocks in the real estate sector presents an opportunity to buy into undervalued companies.
Lineage to Report Third-Quarter 2024 Financial Results on November 6, 2024
NOVI, Mich.--(BUSINESS WIRE)--Lineage, Inc. (NASDAQ: LINE), announced that it will report its financial results for the third quarter of 2024 on Wednesday, November 6, 2024, before market open. A conference call to discuss these results has been scheduled for 8:00...
Animal Spirits Awaken
U.S. equity markets gained for a third-straight week while short-term interest rates declined to two-year lows as "Goldilocks" economic data provided a backdrop of support for dovish Fed policy. Following combined gains of 5% over the prior two weeks, the...
Essential Business Spotlight: Cold Storage
Cold Storage REITs like Americold and Lineage are essential due to their role in reducing food spoilage and supporting the cold chain infrastructure. Key growth drivers include online grocery adoption, increased frozen food consumption, recovering margins, and consolidation opportunities, making...
Source: https://incomestatements.info
Category: Stock Reports